|

TORIPALIMAB INJECTION(JS001 ) Clinical Trials

2 actively recruiting trials

Also known as: Epirubicin, cyclophosphamide, nab-paclitaxel

Pipeline

Phase 2: 2

Top Sponsors

  • Peking University First Hospital1
  • First Affiliated Hospital of Zhejiang University1

Indications

  • Cancer2
  • HR-positive,HER2-negative Breast Cancer1
  • Renal Cancer Metastatic1
  • Targeted Therapy1
  • Radiation Therapy1

Other2 trials

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
Phase 2
SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.